Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer Yakuhin To Sell Kobe Research Lab (Japan)

This article was originally published in PharmAsia News

Executive Summary

Bayer Yakuhin Ltd., a Japanese subsidiary of German pharmaceutical firm Bayer Schering Pharma AG, plans to close a Kobe research laboratory before the end of the year and sell it. The move is part of Bayer's effort to streamline operations after it acquired last year German drugmaker Schering AG and in July consolidated the two firms' Japanese units. The lab has been involved in basic research, including stem cell cultivation, achieving some breakthroughs. Following the merger, however, Bayer Schering decided to concentrate research on cancer, heart disease, gynecological disorders and diagnostic imaging drugs. (Click here for more - May Require Paid Subscription
Advertisement

Related Content

Bayer Shering Pharma Applies For iPS Patent With Japan Patent Office
Advertisement
UsernamePublicRestriction

Register

SC066496

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel